Posted in | News | Nanoelectronics | Graphene

Vorbeck Materials to Use Additional Capital for Sale of Graphene-Based Conductive Inks

Vorbeck Materials Corp. announced today that it has secured an additional $2.785 million in a fully subscribed series 2b financing, which was completed December 30, 2010.

Fairbridge Venture Partners and Stoneham Partners, L.P. led the round, along with individual investors. To date, the company has raised over $8.0 million in private investment.

Vorbeck will use the additional capital to expand sales of its Vor-ink™ conductive ink for printed electronics applications. Vor-ink, which is the world’s first commercial product using graphene, offers the printed electronics industry a highly conductive and flexible conductive ink at a cost well below competing silver-based inks.

With completion of this financing, rapid customer adoption of Vorbeck products, and approval by the EPA for the commercial sale of Vorbeck’s graphene-based conductive inks, Vorbeck Materials is poised for strong growth in 2011.

Source: http://www.vorbeck.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Vorbeck Materials. (2019, February 12). Vorbeck Materials to Use Additional Capital for Sale of Graphene-Based Conductive Inks. AZoNano. Retrieved on November 22, 2024 from https://www.azonano.com/news.aspx?newsID=21132.

  • MLA

    Vorbeck Materials. "Vorbeck Materials to Use Additional Capital for Sale of Graphene-Based Conductive Inks". AZoNano. 22 November 2024. <https://www.azonano.com/news.aspx?newsID=21132>.

  • Chicago

    Vorbeck Materials. "Vorbeck Materials to Use Additional Capital for Sale of Graphene-Based Conductive Inks". AZoNano. https://www.azonano.com/news.aspx?newsID=21132. (accessed November 22, 2024).

  • Harvard

    Vorbeck Materials. 2019. Vorbeck Materials to Use Additional Capital for Sale of Graphene-Based Conductive Inks. AZoNano, viewed 22 November 2024, https://www.azonano.com/news.aspx?newsID=21132.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.